Search Results 1201-1210 of 10274 for total t4

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Total body irradiation, Exte...rnal beam radiation therapy, Head and neck cancer, Prostate cancer, Lung cancer. Show more areas of focus for Quan Chen, Ph.D ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Total body irradiation, Exte...rnal beam radiation therapy, Head and neck cancer, Prostate cancer, Lung cancer. Show more areas of focus for Quan Chen, Ph.D ...

  3. KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma - Mayo Clinic

    t(4;14) confirmed by standard of care FISH testing. Measurable disease, including at least 1 of the following criteria: Serum M protein ≥ 0.50 g/dL (by SPEP) ...

  4. Control-IQ Technology in Individuals with Type 2 Diabetes - Mayo Clinic

    Total daily insulin dose ≤ 200 units/day. Willing to use only aspart (novolog) or lispro (humalog) insulin with the study pump, with no use of concentrated ...

  5. A Long-Term Follow-Up Observational Study To Evaluate Safety In Subjects Who Have Received A Gene-Modified Regulatory T Cell (Treg) Therapeutic - Mayo Clinic

    To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

  6. Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20164173. Home; Arizona Volunteers ...

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate the effectiveness of cilta-cel OOS based on overall response of partial response (PR) or better (overall response rate, ...

  8. Oncology (Medical) - Clinical trials

    The purpose of this study is to systematically and prospectively record accurate and complete ... overall, 7% of patients develop CHF (median follow-up 8.5 years) ...

  9. Clinical trials - Oncology (Medical)

    The primary objective of the study is to evaluate the Overall Survival (OS). A Feasibility Study To Evaluate The Safety Of The TheraSphere Glioblastoma (GBM) ...

  10. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Registration Trial - Mayo Clinic

    ... overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some ...